More News

19 Dec 2017 Evox Therapeutics to Collaborate with Boehringer Ingelheim on Exosome-Mediated Drug Delivery
18 Dec 2017 Autifony Therapeutics and Boehringer Ingelheim collaborate on a novel therapeutic approach to a range of CNS disorders
18 Dec 2017 Regeneron and ISA Pharmaceuticals Announce Strategic Immuno-Oncology Collaboration
16 Dec 2017 Cancer Research UK announces drug discovery collaboration with Celgene Corporation
15 Dec 2017 Orchard Therapeutics and Généthon Announce Gene Therapy Alliance in X-linked Chronic Granulomatous Disease
14 Dec 2017 reMYND Enters Into License Agreement to Further Develop Novel Treatments Improving Beta-cell Health and Insulin Signalling With Novo Nordisk
14 Dec 2017 Bristol-Myers Squibb Granted Exclusive License by Ono Pharmaceutical for Multiple Programs Targeting Immuno-Suppressive Factors in the Tumor Microenvironment
13 Dec 2017 Evotec Enters into Research Collaboration with CRTD to Discover Novel Therapies for Retinal Diseases
12 Dec 2017 Vertex and CRISPR Therapeutics to Co-Develop and Co-Commercialize CTX001 as CRISPR/Cas9 Gene Edited Treatment for Sickle Cell Disease and ß-Thalassemia
12 Dec 2017 Repros Therapeutics Inc.® Announces Acquisition by Allergan plc
11 Dec 2017 Ionis Pharmaceuticals Licenses IONIS-HTT Rx to Partner Following Successful Phase 1/2a Study in Patients with Huntington's Disease
11 Dec 2017 Medigene collaborates with RXi Pharmaceuticals to further sharpen its therapeutic T cells
08 Dec 2017 Gilead Sciences and Kite to Acquire Cell Design Labs
07 Dec 2017 Aerogen Pharma and Lyomark Pharma Partner to Develop Inhaled Surfactant, Begin a Phase 2 Clinical Trial
07 Dec 2017 bluebird bio and TC BioPharm Announce Strategic Collaboration to Research and Develop Gamma Delta CAR T Cell Product Candidates for Cancer Immunotherapy
07 Dec 2017 Alexion and Halozyme Enter License Agreement for ENHANZE Technology
07 Dec 2017 XOMA Announces Exclusive License Agreement for XOMA 358 with Rezolute, Inc.
07 Dec 2017 Carmot Enters a Multi-Year Drug Discovery Collaboration With Amgen
07 Dec 2017 BioInvent and Transgene collaborate on next generation oncolytic viruses encoding an anti-CTLA-4 antibody to treat solid tumors
06 Dec 2017 Ayala Pharmaceuticals, Founded by Israel Biotech Fund, aMoon and Harel Insurance, Enters Exclusive Worldwide License Agreement with Bristol-Myers Squibb (BMS) to Develop Cancer Treatments
06 Dec 2017 TetraGenetics and ModiQuest Collaborating for the Discovery of Therapeutic Antibodies Against KCa3.1
06 Dec 2017 Juno Therapeutics Signs Licensing Agreements with Lilly, OncoTracker, and Fred Hutchinson Cancer Research Center to Advance Its BCMA-Directed Engineered T Cell Program in Multiple Myeloma with Gamma Secretase Inhibition
06 Dec 2017 Obsidian Therapeutics Announces $49.5 Million Series A Financing to Develop Controllable Cell and Gene Therapy Products
05 Dec 2017 CSL and Vitaeris Announce Strategic Partnership with Option to Acquire
05 Dec 2017 Led by OrbiMed Israel and Peter Thiel, ChemomAb Raises $10 Million in Series B Funding

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top